DiaCarta Ltd., a novel molecular diagnostic test developer for cancer and infectious diseases, has received accreditation by the College of American Pathologists (CAP) for its CLIA certified lab. This accreditation is awarded to facilities that meet the high standards of quality, accuracy, and consistency in laboratory services required by CAP and underscores DiaCarta’s leadership and commitment to excellence.

“This CAP Accreditation is a tremendous accomplishment that signifies DiaCarta’s commitment to excellence and I am proud of our team’s dedication in support this major milestone,” says Zheng Li, vice president of Medical Clinical Affairs at DiaCarta. “This achievement reflects our continued adherence to the highest standards of quality, accuracy and consistency in providing clinical diagnostic tests to patients and clinical communities and builds on the success of our recently won New York State CLIA license.”

The U.S. federal government recognizes the CAP Laboratory Accreditation Program as being equal to or more stringent than the government’s own inspection program. During the CAP inspection process, inspectors examine the laboratory’s quality system and records. Included in the inspection is the examination of laboratory staff qualifications, laboratory equipment, safety programs, and overall management practices.

About DiaCarta

DiaCarta is a molecular diagnostics company that has developed innovative technologies to transform patient care by providing effective precision diagnostics using liquid biopsy. Its novel XNA technology is designed to provide a high level of sensitivity as it binds to the wild-type sequence, to enable only the mutant target sequence to be amplified. Using this technology, DiaCarta has developed its ColoScape colorectal cancer mutation test. Powered by its isorbDNA technology that amplifies the signal and requires no RNA/DNA extraction or amplification, DiaCarta has developed its RadTox test to personalize radiation and chemotherapy, mitigate adverse events, and enhance patient care. Based in Pleasanton, California, DiaCarta is ISO certified, GMP-compliant, and offers CLIA certified laboratory services to its customers.